MedTrace Logo

The HIT-TRAP Trial

NCT00196417 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2005-09-20

No results posted yet for this study

Summary

Randomised, double blind trial in non-intensive care trauma patients comparing unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) in heparin-induced thrombocytopenia (HIT).

Conditions

  • Heparin-Induced Thrombocytopenia

Interventions

DRUG

Standard heparin (UFH) versus certoparin (LMWH)

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Andreas Greinacher, Prof. Dr. · Ernst-Moritz-Arndt University Greifswald, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Completion
2005-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196417 on ClinicalTrials.gov